Erfolgreich hinzugefügt!
Kursdaten 
Chart
News + Analysen
Fundamental
Unternehmen
Derivate
Aktion
27.05.2019 17:40:39
|
1. Details of the person discharging managerial responsibilities / person closely associated a) Name
2. Reason for the notification a) Position / status
b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name
b) LEI
4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code
b) Nature of the transaction
c) Price(s) and volume(s)
d) Aggregated information
e) Date of the transaction
f) Place of the transaction
27.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | BB BIOTECH AG |
| Schwertstrasse 6 | |
| 8200 Schaffhausen | |
| Switzerland | |
| Internet: | www.bbbiotech.ch |
| End of News | DGAP News Service |
|
|
51397 27.05.2019
Nachrichten zu BB Biotech AG
| BB Biotech im ersten Quartal mit hohem Verlust (dpa-AFX) | 24.04.20 |
| DGAP-News: BB BIOTECH AG: Konsolidierung beeinflusst Ergebnisentwicklung im 2. Quartal (EQS Group) | 19.07.19 |
| DGAP-News: BB BIOTECH AG: Consolidation leaves a mark on results in the second quarter (EQS Group) | 19.07.19 |
| DGAP-Adhoc: BB Biotech AG publishes its interim report (EQS Group) | 19.07.19 |
| DGAP-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht (EQS Group) | 19.07.19 |
| DGAP-DD: BB BIOTECH AG english (EQS Group) | 27.05.19 |
| DGAP-DD: BB BIOTECH AG deutsch (EQS Group) | 27.05.19 |
| DGAP-News: BB BIOTECH AG: Focus on long-term innovation leads to a strong first quarter of 2019 (EQS Group) | 26.04.19 |
| mehr | |
Aktienempfehlungen zu BB Biotech AG
| 27.08.19 | BB Biotech neutral | Independent Research GmbH | |
| mehr Aktienempfehlungen | |||
